OYO Parent Prism Files Updated DRHP For INR 6,650 Crore IPO

- Advertisement -spot_imgspot_img
- Advertisement -spot_imgspot_img

OYO parent company Prism has filed an amended Draft Red Herring Prospectus for its eagerly awaited initial public offering, a crucial milestone in its long-delayed listing path. The planned sale is a new issuance of shares to the tune of ₹6,650 crore and would be one of the most closely-watched startup public market launches in recent years.

The revised filing follows the Securities and Exchange Board of India’s clearance of Prism earlier this month, after its private DRHP file in late December 2025. The business has previously got shareholder permission at an extraordinary general meeting in December 2025 to raise up to ₹6,650 crore via the IPO. With the revised paperwork in place, Prism is now ready to advance to the next step in the regulatory process before the offer is thrown available to public investors.

Prism said in recent IPO paperwork it intends to spend a major percentage of profits to repay or retire borrowings. The business plans to utilize net proceeds of ₹4,987.50 crore for debt reduction and the remaining for other corporate purposes. Since the matter is totally a new issue, all revenues will go to the corporation and not to current shareholders. This turns the offering into not merely a fundraising exercise, but also a balance-sheet clean-up that might improve Prism’s financial image ahead of listing.

Market estimates indicate the IPO might value Prism at between $7 billion and $8 billion, although the actual valuation will be dependent on market circumstances and investor interest at the time of the debut of the issue. That is less than the more ambitious value projections that had been connected with the company’s past public listing bids, but still substantial enough to put Prism among India’s more important startup-era IPO prospects. The lesser size of the issuance compared with prior intentions is also a sign of a more cautious approach in a volatile market environment.

Everyone has been watching Prism’s listing campaign intently, being one of the most high-profile comeback stories in India’s startup space. Prior to delays and shifting circumstances putting the process on the back burner, the corporation had examined public market prospects. Filing now signals a fresh push into public capital and an effort to strengthen financial discipline via debt repayment and a stricter corporate posture.

The revised DRHP is also important in as far as it means that Prism has reached a point when it will be under the scanner of the public. Investors will look to the prospectus for insights on revenue growth, profitability, customer trends, regional exposure and sustainability of OYO’s business model. These things important for a travel tech and hospitality organization since demand cycles, seasonal travel patterns and macroeconomic circumstances may and do impact the company’s revenues.

If the IPO goes forward as planned, Prism is anticipated to utilize the profits to deleverage and finance the next stage of its growth. This would be particularly essential as the firm strives to portray itself not only as a growth story, but a more mature corporation, financially solid and ready for public markets. That shift will be rewarded by the market, and the next round of responses from investors will be telling.

For now, the revised DRHP is the best indication yet that Prism is gearing up seriously for a public debut. The OYO parent seems to be slowly edging towards what may be one of the largest IPO tales in India’s startup and hospitality market, after years of speculation and repeated delays.

- Advertisement -spot_imgspot_img
Aryan Jakhar
Aryan Jakharhttp://news.prayanmedianetwork.com
Editor and Co-founder at Prayan Media Network. Aryan keeps a close eye on Businesses, Market, Startups, National and World news. He can be reached at aryan.jakhar@prayanmedianetwork.com.
Latest news
- Advertisement -spot_img
Related news
- Advertisement -spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here